Unknown
Who we are
Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer
Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
alloSHRINK – Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Immunotherapy for the Treatment of Advanced Solid Tumor
Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors
Mebendazole as Adjuvant Treatment for Colon Cancer
Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)
